Clinical Trial Update: Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL) [Phase 1]

View source ↗

Summary

This is a phase 1 study of a triple-drug regimen (bendamustine, lenalidomide, and rituximab) in chronic lymphocytic leukemia and non-Hodgkin lymphoma that has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: Georgetown University | Conditions: Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED